Employing Biomarkers to De-risk Therapeutic Development in AD

Time: 11:20 am
day: One-Day Digital Content


  • Aiding the developing of novel therapeutics in clinical trials by inclusion of fluid and imaging biomarkers
  • Exploring AD case study evidence to evaluate the importance of patient selection tools, target engagement/ pharmacodynamic measures and biomarkers of disease progression